logo-loader

Proactive news snapshot: Avacta Group, MySQUAR, Live Company Group …

Published: 10:30 24 Jul 2018 EDT

Newspapers

Avacta Group Plc (LON: AVCT) has agreed a major co-development partnership with a US business. It is teaming up with Bach BioSciences, a company commercialising the research of William Bachovchin, a professor at Tufts University School of Medicine, Boston.

MySQUAR Limited (LON:MYSQ) has launched its second massively multiplayer online role-playing game (MMORPG) in Myanmar.

Live Company Group Plc (LON:LVCG) said it is launching its BRICKLIVE brand in the Dominican Republic, while also bolstering its presence in South Korea.

Rainbow Rare Earths LTD (LON:RBW) sold 350 tonnes of rare earth concentrate in the three months to end June 2018, up significantly from the 125 tonnes sold in the previous quarter, as the ramp-up to full production continues.

Christian Schaffalitzky, the chairman of Eurasia Mining plc (LON:EUA), told shareholders at today’s annual general meeting (AGM) that 2018 has been a great success. The appointment of Techstroy as the contractor for the West Kytlim platinum and gold mine has proven to be a catalyst that has driven the project into a very successful mining season, Schaffalitzky said.

Highlands Natural Resources Plc (LON:HNR) has reported its first revenues during what was a “transformational” six months for the junior oiler. The London-listed firm brought two wells on stream at its East Denver Niobara project in Colorado earlier this year, generating £2.9mln during the four months ended March 31 2018 (2017: Nil).

Learning Technologies Group PLC (LON:LTG) has traded in line with expectations this year and has seen an encouraging increase in recurring revenues.

Sound Energy PLC (LON:SOU) has confirmed the start of civil works in preparation for the planned drilling of the TE-9 well, within the Tendrara licence onshore Morocco. The first stage of civil works sees the construction of an access road to the well site. The explorer also told investors that it has now signed a rig contract for the programme.

Chariot Oil & Gas Limited (LON:CHAR) chief executive Larry Bottomley told investors that the focus for the remainder of 2018 is on the delivery of safe and cost-effective drilling operations in Namibia. The company also continues to seek partnerships throughout its portfolio, mature its exploration prospects and ultimately deliver further funded drilling opportunities.

Savannah Resources Plc (LON:SAV) has appointed experienced lithium consulting engineer Primero Group to lead the feasibility study for the development of the Mina do Barroso lithium project in Portugal.

Sunrise Resources Plc (LON:SRES) has raised £400,000 in a share placing to support the company’s CS Pozzolan-Perlite Project in Nevada, USA. Some 285.7mln new shares are being sold at a price of 0.14p each.

Custodian REIT PLC (LON:CREI) saw its net asset value per share (NAV) climb to 107.8p at the end of the second quarter. The NAV started the quarter at 107.3p. With a dividend of 1.6375p approved for the period, the NAV total return per share for the quarter was 2.0%.

Europa Oil & Gas Holdings Plc (LON:EOG) has updated on the planning process for the Holmwood project, as it submits an application to make new variations to its proposals. For the proposed exploration well site, the company is now seeking to extend the temporary period of the permission for the well site by a further 3 years.

Jersey Oil & Gas (LON:JOG) has been advised that drilling of the Verbier Well in the UK Continental Shelf region of the North Sea has been pushed back a few months. Originally, the plan was to drill the appraisal well this quarter, but operator Equinor (the new name for Statoil) says Verbier will now be the third well in a UK drilling campaign using the West Phoenix rig as opposed to the first.

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

1 hour, 52 minutes ago